Bottom line
What is PCRNX's expense ratio?
PCRNX's expense ratio is 1.18%, or about $118 a year on every $10,000 invested. That is more expensive than 71% of commodities funds we track (median 0.9%). It has no front-end sales load.
Updated Jul 28, 2026
PCRNX fee table
| Net expense ratio | 1.18% |
|---|---|
| Gross expense ratio | 1.36% |
| Management fee | 0.94% |
| Other expenses | 0.29% |
| Acquired fund fees | 0.13% |
| Fee waiver / reimbursement | -0.18% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 28, 2026
What PCRNX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCRNX | $120 | $413 | $727 | $1,619 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.18% expense ratio costs roughly $64,300 in lost growth, versus about $50,300 for the median commodities fund (0.9%).